Maharashtra, India

Nitin Sharadchandra Pradhan

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 50(Granted Patents)


Location History:

  • Thane (West), IN (2014)
  • Maharashtra, IN (2011 - 2016)

Company Filing History:


Years Active: 2011-2016

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: Nitin Sharadchandra Pradhan: Innovator in Pharmaceutical Chemistry

Introduction

Nitin Sharadchandra Pradhan is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel drug formulations. With a total of 11 patents to his name, Pradhan's work has had a substantial impact on the industry.

Latest Patents

Among his latest patents, Pradhan has developed solid state forms of tapentadol salts. This innovation includes novel solid state forms, processes for their preparation, and pharmaceutical compositions aimed at improving treatment methods. The tapentadol salts he has worked on include various forms such as L-(−)-camphorsulfonate salt and dibenzoyl-(L)-tartrate salt, among others. Additionally, he has disclosed an improved process for preparing quinoline-3-carboxamide derivatives, which are crucial for producing high-yield and pure pharmaceutical compounds.

Career Highlights

Throughout his career, Nitin Pradhan has been associated with prominent companies in the pharmaceutical sector, including Actavis Group Ptc Ehf. His work has focused on enhancing drug formulations and processes, contributing to advancements in pharmaceutical manufacturing.

Collaborations

Pradhan has collaborated with notable professionals in the field, including Jon Valgeirsson and Girish Dixit. These collaborations have further enriched his research and development efforts.

Conclusion

Nitin Sharadchandra Pradhan stands out as an influential inventor in pharmaceutical chemistry. His innovative patents and collaborations reflect his commitment to advancing drug development and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…